Evidence map›Paper›PMID 38287193›Full record

ArticleNature structural & molecular biology2024

Variant in the synaptonemal complex protein SYCE2 associates with pregnancy loss through effect on recombination.

Valgerdur Steinthorsdottir, Bjarni V Halldorsson, Hakon Jonsson, Gunnar Palsson, Asmundur Oddsson, David Westergaard, Gudny A Arnadottir, Lilja Stefansdottir, Karina Banasik, M Sean Esplin and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Genomics of pregnancy loss.Journal of assisted reproduction and genetics · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Femtechs take on women's health.Nature biotechnology · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 3 countries.

Valgerdur SteinthorsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland. valgerdur.steinthorsdottir@decode.is.ORCID http://orcid.org/0000-0003-1846-6274
Bjarni V HalldorssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-0756-0767
Hakon JonssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6197-494X
Gunnar PalssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-8231-3961
Asmundur OddssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-4606-5163
David WestergaardNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-0128-8432
Gudny A ArnadottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6571-423X
Lilja StefansdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.
Karina BanasikNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-2489-2499
M Sean EsplinDivision of Maternal and Fetal Medicine, Intermountain Health, Murray, UT, USA.
Thomas Folkmann HansenNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-6703-7762
Søren BrunakNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-0316-5866
Mette NyegaardDepartment of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark.ORCID http://orcid.org/0000-0003-4973-8543
Sisse Rye OstrowskiDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-5288-3851
Ole Birger Vesterager PedersenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-2312-5976
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.ORCID http://orcid.org/0000-0001-6551-6647
DBDS genomics consortium
Gudmar ThorleifssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-4623-9087
Lincoln D NadauldPrecision Genomics, Intermountain Health, Saint George, UT, USA.
Asgeir HaraldssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-5364-7877
Thora SteingrimsdottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Laufey TryggvadottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8067-9030
Ingileif JonsdottirdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-8339-150X
Daniel F GudbjartssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-5222-9857
Eva R HoffmannDepartment of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0002-2588-0652
Patrick SulemdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-7123-6123
Hilma HolmdeCODE genetics/Amgen, Inc., Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-9517-6636
Henriette Svarre NielsenDepartment of Obstetrics and Gynecology, Copenhagen University Hospital, Hvidovre, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-2106-8103
Kari StefanssondeCODE genetics/Amgen, Inc., Reykjavik, Iceland. kstefans@decode.is.ORCID http://orcid.org/0000-0003-1676-864X
deCODE Genetics (Iceland) · ISUniversity of Copenhagen · DKIntermountain Healthcare · USReykjavík University · ISUniversity of Iceland · ISAalborg University · DKAarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-thirds of all human conceptions are lost, in most cases before clinical detection. The lack of detailed understanding of the causes of pregnancy losses constrains focused counseling for future pregnancies. We have previously shown that a missense variant in synaptonemal complex central element protein 2 (SYCE2), in a key residue for the assembly of the synaptonemal complex backbone, associates with recombination traits. Here we show that it also increases risk of pregnancy loss in a genome-wide association analysis on 114,761 women with reported pregnancy loss. We further show that the variant associates with more random placement of crossovers and lower recombination rate in longer chromosomes but higher in the shorter ones. These results support the hypothesis that some pregnancy losses are due to failures in recombination. They further demonstrate that variants with a substantial effect on the quality of recombination can be maintained in the population.

Indexed as

Nuclear ProteinsSynaptonemal ComplexChromosomal Proteins, Non-HistoneFemaleGenome-Wide Association StudyHumansMeiosisPregnancyRecombination, GeneticChromosomal Proteins, Non-HistoneNuclear Proteins

Identifiers

PMID38287193
PMCPMC11026158
OpenAlexW4391317026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.